Rotana Radwan, Pharm.D.
Pharmacist
Health Outcomes Researcher
Bio
Rotana Radwan, Pharm.D., focused her dissertation on measuring preferences for chemotherapy discontinuation due to chemotherapy-induced peripheral neuropathy (CIPN) among patients with metastatic breast cancer. Funded through Massey Comprehensive Cancer Center and the American Cancer Society, Radwan used stated-preference instruments—best-worst scaling and discrete-choice experiment—to measure priorities and preferences for treatment discontinuation due to CIPN among patients with metastatic breast cancer.
Along with her dissertation, Radwan has authored or co-authored five journal articles in the areas of pharmacy practice and oncology as well as published and presented 12 abstracts at national (ASCO, ACCP, AACP, APhA, ASHP) and international (ISPOR) meetings.
She is currently working to finalize and submit three manuscripts based on her research for journal publication. Along with her advisor, Teresa Salgado, they will continue their efforts, working to create a decision aid tool for those experiencing neuropathy to be used in clinical practice.
Research Interests
- Patient/physician communication
- Pharmacist impact on patient quality of life, quality of care, health outcomes
Faculty Advisor
- Teresa Salgado, M.Pharm., Ph.D.
VCU Poster Presentations
- Predictors of Obtaining Cholesterol Screening in the United States: Data from the 2014 Medical Expenditure Panel Survey. APhA Annual Meeting 2021, March 2021 (presented virtually).
- Characterizing the Scope of Practice and Evaluating Performance of Entrustable Professional Activities (EPAs) Performed by Health-System Pharmacy Interns Based on Student Pharmacist Viewpoints. ASHP Annual Meeting 2020, December 2020 (presented virtually).
- Predictors of Pharmacists’ Job Satisfaction: Analysis of the 2018 Virginia Pharmacist Workforce Survey. ACCP Annual Meeting 2020, October 2020 (presented virtually).